UB to co-sponsor 10 local biotech companies at BIO International Convention

BUFFALO, N.Y. — The University at Buffalo’s New York State Center of Excellence in Bioinformatics and Life Sciences, in collaboration with the Buffalo Niagara Medical Campus, Buffalo Niagara Enterprise, MedTech and National Grid, will co-sponsor 10 local biotech companies at the 2015 BIO International Convention, to be held June 15-18 in Philadelphia.

The convention attracts the biggest names in the biotech industry, allowing participants to meet face-to-face with entrepreneurs, scientific businesses and the academic community, and to connect with 4,000-plus participating companies, 1,700 exhibiting companies and a network of c-level executives from 70 countries, to find partners, sustain projects and establish new funding opportunities.

The world’s largest biotechnology exhibition, BIO also provides sessions covering the latest biotech trends, policy issues, licensing and important patent information.

Local companies that will be part of this year’s New York Pavilion include For-Robin, QuaDPharma, HarkerBIO, Zoetic Pharmaceuticals, HemoGenyx LLC, Asana Medical Inc., Ceno Technologies, TheraSyn Pharmaceuticals Inc., Efferent Labs and Global H.

“This is my fourth year attending BIO,” said QuaDPharma President and CEO Stephen Panaro. “BIO is a valuable platform for me to connect with a wide spectrum of life sciences innovations and application areas that can contribute to the ongoing success of QuaDPharma.”

This year’s keynote speakers include journalist Tom Brokaw; Eric Topol, MD, director of the Scripps Translational Science Institute and a leading authority on digital medicine and its impact on health care; and internationally acclaimed musician, educator and leading advocate of American culture Wynton Marsalis.